Clinical Trial Update: Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating home-based treatment of HIV/AIDS patients using Interleukin-2 with or without a tumor necrosis factor antagonist; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Tumor necrosis factor antagonist (TNF antagonist)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infection | Phase 2 | Status: COMPLETED